Corrigendum to “Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis”

Corrigendum to “Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis”

Bibliographic Details
Main Authors:	Jianfeng Shi, Haijian Ying, Juping Du, Bo Shen
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/3953474

Similar Items

Serum Sclerostin Levels in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Jianfeng Shi, et al.
Published: (2017-01-01)

Serum Prolidase Activity in Ankylosing Spondylitis and Rheumatoid Arthritis
by: Demet Uçar, et al.
Published: (2013-08-01)

Serum Prolidase Activity in Ankylosing Spondylitis and Rheumatoid Arthritis
by: Demet Uçar, et al.
Published: (2013-01-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
by: Tacjana Anna Barczyńska, et al.
Published: (2015-12-01)

Molecular studies in ankylosing spondylitis and rheumatoid arthritis
by: Fielder, Mark David
Published: (1996)

Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study
by: Fabio Massimo Perrotta, et al.
Published: (2018-01-01)

Rheumatoid arthritis and ankylosing spondylitis with cervical involvement and characteristics
by: Nevsun Pihtili Tas, et al.
Published: (2019-06-01)

Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
by: Marina Amaral de Ávila Machado, et al.
Published: (2016-01-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Prevalence of low bone mineral density in ankylosing spondylitis, correlation with disease activity, and serum sclerostin levels
by: Anupam Wakhlu, et al.
Published: (2020-01-01)

COEXISTING RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS – A CASE REPORT
by: Ileana Cosmina Filipescu, et al.
Published: (2018-03-01)

Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study.
by: ERIC eTOUSSIROT, et al.
Published: (2013-12-01)

Early signs of myocardial dysfunction in patients with rheumatoid arthritis and ankylosing spondylitis
by: L. I. Feiskhanova, et al.
Published: (2021-01-01)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
by: Kurt de Vlam, et al.
Published: (2020-05-01)

Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis – impact of treatment
by: Piotr Dąbrowski, et al.
Published: (2014-06-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016-10-01)

Serum sclerostin in rheumatoid-induced osteoporosis
by: Ola Gharbia, et al.
Published: (2020-07-01)

Frequency of the use of biological treatment of patients with rheumatoid arthritis and ankylosing spondylitis in Lower Silesia
by: Wojciech Tański, et al.
Published: (2016-09-01)

The immune response to gut bacteria in rheumatoid arthritis, ankylosing spondylitis, and inflammatory bowel disease
by: Tiwana, Harmale Singh
Published: (2006)

TEMPOROMANDIBULAR JOINT INVOLVEMENT IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: A CROSS-SECTIONAL STUDY
by: Cristina Iordache, et al.
Published: (2018-01-01)

Serum Heme Oxygenase-1 and BMP-7 Are Potential Biomarkers for Bone Metabolism in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
by: Tong-ling Yuan, et al.
Published: (2016-01-01)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
by: Gia Deyab, et al.
Published: (2017-01-01)

Serum sclerostin levels in rheumatoid arthritis and correlation with disease activity and bone mineral density
by: Urmila Dhakad, et al.
Published: (2019-01-01)

Serum heat-shock protein-65 antibody levels are elevated but not associated with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis
by: Ulusoy H, et al.
Published: (2018-05-01)

Ankylosing Spondylitis and Rheumatoid Arthritis: Serum Levels of TNF-α and Its Soluble Receptors during the Course of Therapy with Etanercept and Infliximab
by: Martin Schulz, et al.
Published: (2014-01-01)

Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
by: Vandana Bhushan, et al.
Published: (2021-09-01)

Pathogenetic Mechanisms of the Occurrence of Rheumatoid Arthritis and Ankylosing Spondylitis with the Activation-Enzymatic and Phenotypic Features of Lymphocytes
by: Lychkovska N., et al.
Published: (2018-09-01)

Coexistence of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren Syndrome, Antiphospholipid Syndrome, and Ankylosing Spondylitis
by: Moshiur Rahman Khasru, et al.
Published: (2021-01-01)

Association of homocysteine with ankylosing spondylitis: a systematic review and meta-analysis
by: Hui-hui Li, et al.
Published: (2021-03-01)

Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis
by: Seulkee Lee, et al.
Published: (2021-10-01)

Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)

Ankylosing spondylitis
by: Mark Hancock
Published: (2016-10-01)

Ankylosing spondylitis
by: Mukesh Edavalath
Published: (2010-01-01)

ANKYLOSING SPONDYLITIS
by: I. V. Soldatenko
Published: (2013-12-01)

Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study
by: Ziga Rotar, et al.
Published: (2020-02-01)

Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
by: Maria G. Tektonidou, et al.
Published: (2020-09-01)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
by: Fabrizio Cantini, et al.
Published: (2017-01-01)

Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?
by: Jean-Marie Berthelot, et al.
Published: (2019-11-01)

Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients
by: Katie L. Druce, et al.
Published: (2018-05-01)